Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.54 USD
+0.76 (1.17%)
Updated May 6, 2024 04:00 PM ET
After-Market: $65.46 -0.08 (-0.12%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
GILD 65.54 +0.76(1.17%)
Will GILD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for GILD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GILD
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Other News for GILD
Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back
How Is The Market Feeling About Gilead Sciences?
Gilead Sciences Unusual Options Activity For May 06
Pharma R&D productivity seen improving for the first time in years - Deloitte
Interesting GILD Put And Call Options For June 14th